FDA Import Refusal ARE-3999657-9/30002/1 — COMPLEMENTARY COMPOUNDING PHARMACY
The FDA refused shipment ARE-3999657-9/30002/1 from COMPLEMENTARY COMPOUNDING PHARMACY (Australia) on Feb 26, 2026. The refused product falls under Drugs and Biologics — ANTI-DIABETIC N.E.C.. Cited charges: 118,2280,3280,71,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 26, 2026
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK99 ANTI-DIABETIC N.E.C.
- Charges
- 118,2280,3280,71,75